INTI LABS
Pioneering less invasive and more accurate IVF testing solutions
ora™
Introducing the first and only non-invasive endometrial receptivity test
MIRA™
miRNA-based Receptivity Analysis
MIRA™ is a miRNA-based endometrial receptivity test that determines the optimal time for embryo transfer.
Our microRNA (miRNA) biomarkers allow for a less invasive biopsy procedure and more reliable results, increasing the chances of a successful IVF treatment cycle.
HOW DOES INTI LABS HELP HEALTHCARE PROFESSIONALS?
We support healthcare professionals worldwide in their efforts to raise IVF success rates. Our solution provides valuable insight during the IVF treatment cycle to ensure individualized care for patients.
Learn HowHOW CAN FAMILIES BENEFIT FROM INTI LABS’ SOLUTIONS?
We work to stay at the forefront of the issues families face when undergoing IVF, partnering with healthcare professionals to deliver better testing solutions for patients.
Learn HowOUR COMMITMENTS
ASSISTING HEALTHCARE PROFESSIONALS
Inti Labs collaborates with clinics, service providers, and distributors worldwide to deliver impactful solutions to fertility specialists and their patients.
IMPROVING IVF SUCCESS RATES
Our tests are designed to offer more accurate, less-invasive solutions, reducing the likelihood of additional treatment cycles while enhancing the overall patient experience.
REFINING THE FERTILITY JOURNEY
Inti Labs continues to progress the reproductive healthcare landscape for professionals and families, empowering each to make the most informed decisions regarding their treatment plan.
DR. BARRY BEHR AND INTI LABS
Inti Labs’ Chief Technology Officer Dr. Barry Behr is a renowned embryologist with an extensive history of oocyte (egg) and embryo research.
Keep an eye on our blog, where Dr. Behr will be sharing bite-sized insights into what goes on in an IVF lab.